SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-066245
Filing Date
2023-11-28
Accepted
2023-11-28 07:22:15
Documents
15
Period of Report
2023-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20231127.htm   iXBRL 8-K 52822
2 EX-10.1 pyxs-ex10_1.htm EX-10.1 106815
3 EX-99.1 pyxs-ex99_1.htm EX-99.1 16013
4 GRAPHIC img244827169_0.jpg GRAPHIC 7119
  Complete submission text file 0000950170-23-066245.txt   332435

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20231127.xsd EX-101.SCH 2472
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20231127_lab.xml EX-101.LAB 14010
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20231127_pre.xml EX-101.PRE 10289
9 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20231127_htm.xml XML 4911
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 231441892
SIC: 2834 Pharmaceutical Preparations